Please assess the completion status of the following clinical trial:

Trial Title: A Study in South Korea Using Medical Records to Look at Different Treatments for Chronic Obstructive Airway Disease (COPD)

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: RETROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Diagnosed with COPD \[based on ICD-10 code(J43.x-44.x except J430), as the primary or within the fourth secondary diagnosis and initiated LAMA or ICS/LABA more than twice a year from Jan 1, 2005 to Apr 30 2016\].~* Age \>55 years old~Exclusion Criteria:~* Prescription history with any long acting bronchodilator for maintenance therapy (the patient should be inhaler naïve)~* Prescription history with ipratropium bromide~* Prescription history with Leukotriene receptor antagonist(LTRA) or ICS~* Patients with lung cancer, IPF, ILD or lung transplantation at the time of COPD diagnosis

- Gender: ALL
- Minimum Age: 55 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- LAMA (Type: None): Chronic obstructive pulmonary disease (COPD) patients who were prescribed long-acting muscarinic antagonists (LAMA) monotherapy between 01 January 2005 and 30 April 2015.
- ICS/LABA (Type: None): Chronic obstructive pulmonary disease (COPD) patients who were prescribed a fixed-dose combination (FDC) of inhaled corticosteroid (ICS)/long-acting beta agonists (LABA) between 01 January 2005 and 30 April 2015.

Based on this trial design, predict the completion outcome and termination type (if applicable).